No Data
No Data
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Roche Holding AG Rises Thursday
Erste Group Initiates ROCHE HOLDING AG(RHHBY.US) With Hold Rating
Roche's Antibody Against Alzheimer's Looks the Best Yet -- Barrons.com
Roche Reports Positive New Data for Alzheimer's Disease Test Under Development
New England Journal of Medicine Publishes Landmark Phase III Results for Genentech's Itovebi, Showing More Than Doubling of Progression-Free Survival in Certain Type of HR-Positive Advanced Breast Cancer
Asyaari : @Ryand83 we shall all support this move
WAITFOR88 : Yes. I support, too.
steven smith38 : yes. how much. funds do u need on my end. I want my name in the class action
Ryand83 OP : I think we should give it time before jumping the gun. They could be needing regulatory approval for what they plan on doing and we must respect the quiet time if that is the case. I smell $$.